The stock of Akorn, Inc. (NASDAQ:AKRX) is a huge mover today! The stock is down 4.14% or $1.01 after the news, hitting $23.36 per share. About 920,363 shares traded hands. Akorn, Inc. (NASDAQ:AKRX) has declined 44.32% since August 19, 2015 and is downtrending. It has underperformed by 42.22% the S&P500. The move comes after 8 months negative chart setup for the $2.63 billion company. It was reported on Mar, 28 by Barchart.com. We have $21.96 PT which if reached, will make NASDAQ:AKRX worth $157.80M less.
Out of 13 analysts covering Akorn Inc (NASDAQ:AKRX), 11 rate it “Buy”, 0 “Sell”, while 4 “Hold”. This means 73% are positive. Akorn Inc was the topic in 14 analyst reports since July 21, 2015 according to StockzIntelligence Inc.
According to Zacks Investment Research, “Akorn, Inc. manufactures and markets diagnostic and therapeutic pharmaceuticals in specialty areas such as ophthalmology, rheumatology, anesthesia and antidotes, among others. They also market ophthalmic surgical instruments and related products. Customers include physicians, optometrists, wholesalers, group purchasing organizations and other pharmaceutical companies. They also provide contract manufacturing services.”
Akorn, Inc. - Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings with MarketBeat.com’s FREE daily email newsletter.